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Abstract 
Klebsiella pneumoniae is an opportunistic Gram-negative nonmotile bacteria that causes 
nosocomial infections. In these bacteria, nutrients as well as antibiotics are able to diffuse 
through the outer membrane via outer membrane porins, transmembrane protein channels.  Loss 
of outer membrane porins, increased capsule production, and a highly mucoid phenotype are 
commonly observed among antibiotic resistant isolates of this pathogen. The goal of this study 
was to investigate changes in outer membrane porin expression and capsular polysaccharide 
production by K. pneumoniae as it transitions to a β-lactam antibiotic resistant phenotype. 
Klebsiella pneumoniae strain 43816, which is susceptible to β-lactam antibiotics such as 
cepthalothin, was exposed to increasing concentrations of cephalothin over a 14-day period. 
During this period, daily samples of the bacteria were assessed for capsule synthesis, gene 
expression analysis, and changes in the physical appearance of the culture. At the end of the 14-
day exposure, cells had assimilated to survive in 7.5 µg/mL of cephalothin, and had taken on a 
highly mucoid phenotype. High levels of capsular polysaccharides synthesis were confirmed by 
the uronic acid assay. Minimum inhibitory concentration assay showed treated cultures had 
become highly resistant to cephalothin. Two-step RT-qPCR demonstrated that this assimilated 
bacteria exhibited upregulation of magA, which has been linked to invasive, mucoid forms of 
Klebsiella infection. Additionally, cultures at the end of the treatment consistently showed 
downregulation of ompK35 and ompK36 and upregulation of ompK26. These data demonstrate 
that low-level exposure to cephalothin can induce significant changes in cellular phenotype that 
may impact both the resistance and virulence profile. 
 
 
 
Introduction 
 
 Klebsiella pneumoniae is a Gram-negative nonmotile opportunistic bacterium frequently 
responsible for nosocomial infections. This bacteria is abundant in the normal flora of humans, 
particularly in mucosal surfaces such as the nasopharynx and intestinal tract. Development of 
infection by opportunistic pathogens only begins once the immune system has been 
compromised. In the clinical realm, it is well known for being the culprit of community-acquired 
bacterial pneumonia. K. pneumoniae is also responsible for other infections, including urinary 
tract infections, soft tissue infections, and septicemia (Podschun 1998). It has been reported that 
K. pneumoniae is responsible for an estimated 20% of bacterial sepsis cases. Due to young 
children’s immature immune system, patients in pediatric wards where systemic infections can 
easily set in are especially susceptible to K. pneumoniae (Neuhauser 2003). 
 Recent data published by the Center for Disease Control has shown that in the past decade, 
infections by K. pneumoniae has significantly increased and that up to 50% of the strains in these 
cases have developed resistance to modern antibiotics (CDC 2013, Landman 2007). These 
clinical isolates are resistant to a wide spectrum of antibiotics, even antibiotics reserved as a last 
resort due its harsh effects on the liver. There has been an abundance of research on K. 
pneunomiae in its resistant state, but no study has focused on its transition from a susceptible to 
resistant state. Studying the pathogenesis associated with K. pneumoniae will provide a 
fundamental understanding of its mechanism and allow for alternative treatments of infection to 
be developed.   
 Antibiotic resistance mechanisms are related to alterations within the bacterial membrane. 
The structure of Gram-negative bacteria involves two membranes, the outer membrane and the 
inner membrane. The outer membrane serves as a barrier and protects internal components of 
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bacteria from harmful molecules. On the outer membrane, there are proteins called outer 
membrane porins (OMP). These β-barrel proteins are the gateway for which antibiotics can 
transit through the outer membrane and go on to disrupt biochemical pathways, such as cell wall 
synthesis, essential to the survival of bacteria. Outer membrane porins are also essential for 
bacteria as it allows for diffusion of nutrients across the outer membrane. Loss of OMPs has 
been associated with cephalosporin antibiotic resistance acquisition in various bacterial strains 
(Hernandez-Alles 2000). This family of antibiotics contain a β-lactam ring that inhibits proper 
assembly of the bacterial cell wall once diffused through the porins. When exposed to 
cephalosporins, K. pneumoniae are able to downregulate the expression of these porins. The 
downregulation of OMPs can enhance the survival of bacteria and allow for activation of defense 
mechanisms that breaks down the structure of antibiotics (Martinez-Martinez 1999).  
 Klebsiella pneumoniae utilizes a variety of defense mechanisms to combat the deleterious 
effects of antibiotics diffusing into the periplasmic space. Outer membrane porin loss allows for 
the removal of a gate through which antibiotics can pass. Upregulation of efflux pumps will 
result in rapid removal of antibiotics into the extracellular space (Bialek-Davenet 2015, Padilla 
2010). Extended spectrum β-lactamases, which are highly characteristic in resistant clinical 
isolates of K. pneumoniae, work to cleave and inactivate β-lactam antibiotics such as 
cephalothin. Finally, the increased production of capsular polysaccharides coats the bacterial cell 
with a barrier that is much less permeable to antibiotics. The combination of these membrane 
alterations have been known for the development of antibiotic resistance within K. pneumoniae. 
 Specific loss of OMPs has been shown to be a key feature within antibiotic resistant strains 
of K. pneumoniae, among other numerous species (Domenech-Sanchez 2003, Wang 2009). Of 
particular interest in the current study are the following outer membrane porins: OmpK26, 
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OmpK35, and OmpK36. OmpK35 and OmpK36 have been shown to be absent in K. 
pneumoniae strains resistant to antibiotics, particularly antibiotics within the family of 
cephalosporins (Domenech-Sanchez 2003, Kaczmarek 2006, Tsai 2011). OmpK35 and OmpK36 
are major nonspecific outer membrane porins that allow for diffusion of numerous nutrients as 
well as deleterious antibiotics across the cell membrane and into the periplasmic space. In 
contrast, OmpK26 has been shown to be produced in abundance once OmpK35 and OmpK36 are 
lost. OmpK26 is a compensatory porin that sustains the fitness of K. pneumoniae and allows it to 
possess antibiotic resistance (Garcia-Sureda 2011). The alterations to these three outer membrane 
porins will be investigated as K. pneumoniae transitions to antibiotic resistant state. 
 Capsular polysaccharides aid in resistance largely due to decreasing the permeability of 
antibiotics through the outer membrane and into the periplasmic space. Clinically resistant 
strains of K. pneumoniae exhibit a hypermucoid phenotype that aid in conferring resistance to a 
wide spectrum of antibiotics as well as being responsible for causing liver abscesses. A gene 
cluster with 18 genetic components has been proposed to control production of capsular 
polysaccharides (Yeh 2006). MagA is a virulence gene most commonly linked to invasive 
mucoid forms of K. pneumoniae infection (Fang 2004). Other genes of interest in this present 
study include rmpA and wza. RmpA has been identified as being important in regulating capsular 
polysaccharide biosynthesis and wza is vital in the transport of capsular polysaccharides (Cheng 
2010, Everard 2010). Transcriptional investigation of these three genes will aid in understanding 
the shift of capsular polysaccharide biosynthesis as K. pneumoniae transitions to an antibiotic 
resistant state.  
 The antibiotic that will be used in this study is cephalothin from the cephalosporin family 
of antibiotics. Cephalothin is an antibiotic commonly used in clinical settings to treat bacterial 
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infections and resistance acquisition occurs frequently. The purpose of this study is to investigate 
changes outer membrane porin expression and capsule polysaccharide production by K. 
pneumoniae as it transitions to a β-lactam antibiotic resistant state. As K. pneumoniae is exposed 
to increasing concentrations of cephalothin, it was hypothesized that gene expression levels of all 
three OMPs will fluctuate and allow for cephalothin assimilation. Furthermore, capsular 
polysaccharide production was expected to increase over time as an antibiotic defense 
mechanism. It was found that the cephalothin assimilation K. pneumoniae cultures exhibited 
downregulation of OmpK35 and OmpK36 while upregulating OmpK26. Furthermore, 
assimilated cultures obtained a mucoid phenotype with highly elevated levels of capsular 
polysaccharide production. Investigating these cellular and physiological changes allows for the 
understanding of the precise time point during which antibiotic resistance is developed. 
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Materials and Methods 
 
Bacterial Culture and Induction of Resistant Strain. Klebsiella pneumoniae lab strain 43816 
(ATCC) was grown overnight in 5mL LB media and incubated in a Thermo Scientific rotational 
shaker at 37ºC (Figure 1). From the overnight culture, 50 µL was removed and added to four 
separate culture tubes. Two culture tubes contained LB media with cephalothin at a 
concentration of 1.0 µg/mL. The remaining two tubes only contained LB media and served as the 
control. The culture was allowed to grow until early logarithmic phase (OD600 = 1.0) and total 
RNA was purified using Qiagen RNEasy Kit and Qiagen RNAprotect Bacteria Reagent. After 12 
hours of the initial inoculation, 50 µL of bacterial was removed and added to four new test tubes 
containing fresh 5 mL LB media. The conditions remained the same. Bacterial cultures were 
once again allowed to grow to an early logarithmic phase and total RNA was extracted. At 24 
hours after the initial inoculation, 50 µL of each sample was added to a new set of test tubes 
containing fresh 5 mL of LB media. The concentration of cephalothin was then increased by 0.5 
µg/mL. This 24 hour procedural cycle was repeated daily, totaling to 14 days of cephalothin 
treatment.  
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Figure 1 Induction of Klebsiella pneumoniae assimilation to increasing concentrations of 
cephalothin. 
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Gene Expression Quantification With Two-Step RT-qPCR. Total RNA from each sample 
was used to synthesize cDNA with NEB ProtoScript II Reverse Transcriptase and random 
hexamers primer. Gene of interest primers (Table 1) and synthesis cDNA was used to perform 
RT-PCR in combination with Sigma-Aldrich LuminoCt SYBR Green qPCR ReadyMix. 
Utilizing GapA for normalization, fold changes in gene expression were calculated through the 
2ΔΔCT method (2001).   
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Table 1 Specific primers used in two-step RT-qPCR amplification of target interest genes in 
Klebsiella pneumoniae 43816. 
 
Target Gene Primer Sequence 
 
magA 
   Forward 
   Reverse 
 
 
5’—TGGCCAGTCCGAAAGTGAACGAAT—3’ 
5’—TGCCAACAATTCCCGTTTCTGCTG—3’ 
 
ompK26 
   Forward 
   Reverse 
 
 
5’—GAACAACGCCGGCAAAGATGATGA—3’ 
5’—AGCTGCGGGCATAGACATAGTTCA—3’ 
 
ompK35 
   Forward 
   Reverse 
 
 
5’—TTCGACAACGGTATCGCACTGTCT—3’ 
5’—AGTACATGACGGCCGCATAGATGT—3’ 
 
ompK36 
   Forward 
   Reverse 
 
 
5’—TCAGCGTGGTTTCGCATACTCTA—3’ 
5’—TATTTCAGACCGCCGGTGTAGGTT—3’ 
 
rmpA 
   Forward 
   Reverse 
 
 
5’—ACTGGACTACCTCTGTTTCATATTAC—3’ 
5’—ATCCTGCAGTCAACCAATACTC—3’ 
 
wza 
   Forward 
   Reverse 
 
 
5’—GGATCACCCGGAATTGACTAC—3’ 
5’—TTCCAGCTACTTGGCACCTTAC—3’ 
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Minimum Inhibitory Concentration Assay to Confirm Assimilation to Cephalothin. 
Cephalothin treated, untreated, and Klebsiella pneumoniae lab strain 43816 cultures were 
utilized in this MIC assay. In a 96-well polystyrene plate, cephalothin concentration range of 500 
µg/mL to 0.49 µg/mL were used, where each step was a serial dilution. Bacterial samples were 
diluted in 300 µL of LB media in each well and incubated for 10 hours at 37 ℃ without shaking. 
The growth of K. pneumoniae at varying cephalothin concentrations was assessed using a 
spectrophotometric plate reader.  
 
Capsular Polysaccharide Extraction. Samples were grown overnight from glycerol stock with 
cephalothin and 500 µL treated with 100 µL of 1% Zwittergent 3-14 detergent in 100 mM citric 
acid (pH 2.0) for 30 minutes at 50 ℃, with vortexing. The bacteria were then pelleted by 
centrifugation (14,000 RPM, 5 minutes) and 300 µL of supernatant was then transferred to a new 
tube. Room temperature absolute ethanol was added to a final concentration of 80%. The CPS 
was allowed to precipitate at 4 ℃ for 30 minutes and then centrifuged (14,000 RPM, 5 minutes). 
The supernatants were decanted thoroughly and precipitates were allowed to dry on layer of 
laboratory absorbents. Samples were allowed to resuspend overnight in 250 µL of 100 mM HCl. 
This protocol was an adaptation from Domenico et al. (1989). 
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Quantification of Uronic Acid. Xanthan gum was used as a positive control in place of bacterial 
cultures (Mojica 2007) and a standard curve was generated. As adapted from Blumenkrantz et al. 
(1973), 0.2 mL of overnight samples were added to 1.2 mL of H2SO4/Tetraborate solution. All 
new tubes used in this assay were kept refrigerated beforehand. The samples were mixed well 
and heated in a water bath at 100 ℃ for 5 minutes. The tubes were then removed and cooled in an 
ice-water bath with 20 µL of a meta-hydroxydiphenyl in NaOH solution added. All samples were 
incubated for 10 minutes at room temperature and the samples’ absorbances were measured at 
520 nm using a UNICO Spectrophotometer.  
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Results 
 As antibiotic concentrations increased, we observed changes to the culture morphology. 
This observation started at Day 2 (corresponding to a cephalothin concentration of 1.5 µg/mL) 
with increasing intensity at each subsequent treatment day and higher doses of cephalothin. 
Cephalothin treated bacterial cultures started producing small precipitates at early logarithmic 
growth phase, and finally exhibiting a distinct mucoid phenotype at the end of the 12-hour period 
(Figure 2). A distinct mucoid phenotype was apparent on the sides of the test tube and possessed 
a viscous characteristic. 
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Figure 2 Cephalothin treated bacterial cultures exhibited a mucoid phenotype (right), compared 
to the untreated cultures (left). Viscous residues adhering to the sides of the growth test tube 
indicated the mucoid phenotype.  
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 Klebsiella pneumoniae lab strain 43816 was used to start the treated and untreated cultures. 
From the overnight culture of K. pneumoniae 43816, samples were treated with a non-inhibitory 
concentration of cephalothin and allowed to grow to early logarithmic growth phase. Twelve 
hours after the initial inoculation, cultures were transferred to fresh LB media containing the 
same concentration of cephalothin. Another 12 hours later, cultures were transferred to new LB 
media and the concentration of cephalothin was increased. This cycle of culture transfers and 
antibiotic treatment was repeated for a total of 14 days (Figure 1).  
 Bacterial cultures treated with cephalothin exhibited a greatly reduced growth rate, 
indicative of a high stress level (Figures 3a and 3b). As early as the second day of treatment, 
treated cultures required as long as 400 minutes to reach the early logarithmic growth phase 
(OD600 = 1.0) while untreated cultures only required approximately 120-160 minutes. For the 
entire duration of the 14-day treatment, treated cultures required more time to reach the required 
optical density. Initially, treated cultures required upwards of an extra 227 minutes, on average, 
to reach early logarithmic growth phase. This gap was eventually reduced to a difference as little 
as 25 minutes as the treated started to assimilate. However, at the higher cephalothin 
concentration (6.5 µg/mL), the difference in growth time between treated and untreated cultures 
was as much as 240 minutes. 
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a 
 
 
b 
 
 
Figure 3 Amount of time (minutes) bacterial culture required to reach early logarithmic growth 
phase (OD600 = 1.0) was lengthened in treated samples. Data shown represents Days 1-7 (a) and 
Days 8-14 (b). Each point on the x-axis represents a 12-hour interval, where cultures were 
transferred to fresh LB media and cephalothin was renewed. The concentration of cephalothin 
was increased every 24 hours. 
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 A minimum inhibitory concentration assay was performed using both Day 14 assimilated 
cultures and Day 14 untreated cultures. Both Day 14 assimilated cultures exhibited efficient 
growth in a cephalothin dosage they were last exposed to (Figure 4). At half of that 
concentration, both Day 14 assimilated cultures grew almost as well as the K. pneumoniae 43816 
control. These results suggest that the antibiotic treated K. pneumoniae cultures had assimilated 
to growing in a cephalothin rich environment.  
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Figure 4 Minimum Inhibitory Concentration assay confirmed treated cultures have assimilated to 
a cephalothin rich environment. Absorbance values were measured 10 hours after inoculation of 
cultures. 
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 In order to investigate transcriptional activity of antibiotic resistance associated genes, 
two-step RT-qPCR was performed. The two major nonspecific outer membrane porins, OmpK35 
and OmpK36, prevents the entry of cephalothin when downregulated while upregulation of the 
specific porin OmpK26 allows for diffusion of only nutrients. Initially, all three outer membrane 
porin genes were highly upregulated in the treated samples (Figure 5). As the cephalothin drug 
concentration increased throughout the 14-day treatment, the gene expression levels fluctuated 
and mostly showed trend of downregulation. At the end of the 14-day antibiotic treatment, 
OmpK35 and OmpK36 were both downregulated. Contrarily, OmpK26 was highly upregulated. 
This is consistent with what is known about the major outer membrane porins. OmpK35 and 
OmpK36 is typically downregulated in antibiotic resistant clinical strains of K. pneumoniae 
while OmpK26 is upregulated to help maintain fitness. These results suggest the cephalothin 
treated K. pneumoniae cultures was assimilating to the antibiotic rich environment through 
transcriptional regulation of essential outer membrane porins. 
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Figure 5 Fold change in gene expression of major outer membrane porin genes. Data shown 
indicates the average fold change in gene expression of treated cultures, compared to untreated 
cultures. Each data point on the x-axis represents an antibiotic treatment interval. 
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 As the concentration of cephalothin increased over the course of the 14-day treatment, the 
mucoid phenotype became increasingly more apparent. The initial stress caused by exposure to a 
low dose of cephalothin induced the upregulation of rmpA and wza transcripts, but no 
upregulation of magA was observed (Figure 6). Towards the middle of the treatment at a 
cephalothin concentration of 3.5 µg/mL, magA had a fold change in gene expression of 25.57 
while rmpA and wza had a fold change of 2.93 and 2.21, respectively. All three genes associated 
with the biosynthesis of capsular polysaccharides still remained upregulated by the end of the 14-
day treatment.  
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Figure 6 Fold change in gene expression of genes associated with capsular polysaccharide 
biosynthesis. Data shown indicates the average fold change in gene expression of treated 
cultures, compared to untreated cultures. Each point on the x-axis represents an antibiotic 
interval.  
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Clinical strains of Klebsiella pneumoniae that are resistant to a spectrum of antibiotics 
typically exhibit a highly mucoid phenotype. Elevated levels of capsular polysaccharides provide 
an impermeable barrier inhibiting antibiotic passage through the outer membrane. Capsular 
polysaccharides were extracted from K. pneumoniae cultures in the 14-day treatment in order to 
assess biosynthesis levels. Uronic acids are present in tandem repeats within capsular 
polysaccharides. Spectrophotometric absorbance quantitation of uronic acid using a wavelength 
of 520nm allowed for the indirect measurement of capsular polysaccharide production by each 
bacterial culture (Figure 7). Initially, uronic acid levels were low in both treated and untreated 
samples. Day 11 and Day 14 (corresponding to cephalothin concentrations of 6 and 7.5 µg/mL, 
respectively) exhibited greatly elevated levels of uronic acid. Treated cultures that showed 
upregulation of capsular polysaccharide gene transcripts also had increased uronic acid levels.  
These data suggest that in response to higher concentrations of cephalothin, K. pneumoniae 
produced higher amounts of capsular polysaccharide, as indicated by elevated levels of uronic 
acid.  
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Figure 7 Cephalothin treated samples contained a higher concentration of uronic acid, indicative 
of elevated capsular polysaccharide biosynthesis. Data shown represents the average of treated 
and untreated samples. Each data point on the x-axis represents an antibiotic treatment interval. 
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Discussion 
 Nosocomial infections by Klebsiella pneumoniae are widely studied in the clinical realm. 
These pathogens typically thrive in the clinical setting due to increased presence of patients that 
are immunocompromised. Even with an aggressive antibiotic regimen prescribed, the immune 
system is unable to completely rid of the opportunistic strains, leading to antibiotic resistance 
development and proliferation of resistant K. pneumoniae. Assimilations such as increased β-
lactamase activity, differential regulation of outer membrane porins, upregulation of efflux 
pumps, and increased production of capsular polysaccharides all influence antibiotic resistance in 
K. pneumoniae. Similarly, other bacterial species, namely Escherichia coli, utilize assimilations 
such as acquiring plasmids coding for β-lactamases to evolve antibiotic resistance (Adler 2013). 
Here, we have shown that laboratory induced cephalothin resistant Klebsiella pneumoniae 
gradually altered its outer membrane porin expression and capsular polysaccharide biosynthesis 
in order to increase survivability. The results of this study have also hinted at a critical point 
during which cephalothin resistance developed.  
 In order to induce antibiotic resistance, Klebsiella pneumoniae 43816 was initially exposed 
to a non-inhibitory concentration of cephalothin and then the concentration was gradually 
increased. The treatment of Klebsiella pneumoniae with increasing concentrations of cephalothin 
greatly reduced its growth rate. Throughout the entire duration of the 14-day antibiotic treatment, 
both treated cultures required a longer amount of time to reach an OD600 of 1.0. This can suggest 
that the bacteria were possibly stressed and that surviving cells were forced to utilize assimilative 
mechanisms until it was able to proliferate and enter a logarithmic growth phase. As early as Day 
2, treated cultures started showing formation of faint precipitates and a slight mucoid phenotype. 
The mucoid phenotype was much more pronounced and distinct towards the middle of the 14-
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day treatment, where thick residues formed and stuck to the sides of the growth test tubes. 
Elevated capsular polysaccharide production as confirmed by uronic acid quantitation was 
consistent with this observation. By the end of the 14-day antibiotic treatment, cultures treated 
with cephalothin exhibited a very thick and slimy coating on the sides of the growth test tube 
above the LB media level. It has been previously shown that antibiotic presence at MIC levels is 
sufficient to induce hyper production of capsular polysaccharides (Held 1995). Other bacterial 
species such as Acinetobacter baumannii have also been shown to respond to presence of 
antibiotics by significantly increasing production of capsular polysaccharide as one defense 
mechanism  (Geisinger 2015). K. pneumoniae strains with this ‘hypermucoviscous’ phenotype 
have been classified to be associated with numerous invasive diseases, or community-acquired 
K. pneumonia bacteraemia (Lee 2006).  
 In the clinical realm, antibiotic resistant strains of Klebsiella pneumoniae commonly cause 
abscesses, particularly liver abscess. Capsular serotype K1 of Klebsiella pneumoniae containing 
the loci with magA and wza has been identified as one of the leading serotypes associated with 
primary pyrogenic liver abscess (Chuang 2006, Fang 2010). The gene wza has been identified as 
having an important role in the transport of capsular polysaccharides (Evrard 2010). Wza codes 
for an integral outer membrane protein facilitating the transport of capsular polymers across the 
bacterial membrane to its extracellular space (Dong 2006). It has also been suggested that rmpA 
is an important regulator and aids in initiating capsular polysaccharide biosynthesis (Cheng 
2010). The synergistic effect and prevalence of both magA and rmpA induce the 
‘hypermucoviscous’ phenotype and is responsible for numerous cases of K. pneumoniae 
bacteraemia (Chang 2013, Yu 2006). Their prevalence can be largely due to capsular 
polysaccharides significantly inhibiting the actions of antimicrobial peptides and the innate 
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immune system (Campos 2004).  
 In this study, initial exposure to cephalothin stressed K. pneumoniae and at the 
transcriptional level, many of the genes of interest were upregulated. As concentrations of 
cephalothin increased, gene expression levels fluctuated until Day 6 (corresponding to a 
cephalothin concentration of 6 µg/mL), where there is consistent differential expression of outer 
membrane porin genes linked to antibiotic resistance. At the end of the 14-day treatment, 
cephalothin treated K. pneumoniae cultures consistently upregulated ompK26 while 
downregulating ompK35 and ompK36. Assimilation of cephalothin was confirmed by an MIC 
assay and qPCR data suggested that K. pneumoniae likely became resistant to cephalothin 
around Day 6. Downregulation of ompK35/ompK36 greatly reduced the ability of cephalothin to 
diffuse into the periplasmic space and inhibit growth while the upregulation of ompK26 helped to 
maintain fitness.  
 A distinct mucoid phenotype was also observed starting on Day 6. Genes associated with 
biosynthesis of capsular polysaccharides, magA, rmpA, and wza, were highly upregulated at this 
time point and persisted until the end of the 14-day treatment. Uronic acid quantitation also 
showed increased presence of capsular polysaccharides in cephalothin treated cultures starting at 
Day 6. These factors help to explain that K. pneumoniae had started to become assimilated to a 
cephalothin rich environment as a denser network of capsular polysaccharides can reduce the 
diffusion of cephalothin across the bacterial outer membrane. After all, resistance is futile. 
 The findings of this study indicated that lower doses of cephalothin could initiate dramatic 
cellular and physiological changes within Klebsiella pneumoniae that leads to increased survival 
and antibiotic resistance. A typical antibiotic regimen prescribed by physicians includes 14-day 
doses of respective antibiotics. However, many patients often do not conclude the treatment 
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regimen and can fall ill to another bacterial infection. Subsequent treatments of more antibiotics 
fail to work due to the acquisition of antibiotic resistant strains. Furthermore, these patients pose 
a significant risk to other immunocompromised patients, as they are likely to spread these 
antibiotic resistant strains. 
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